StratomeX Visual Analysis of Large-Scale Heterogeneous Genomics Data for Cancer Subtype Characterization
|
|
- Ethel Dean
- 5 years ago
- Views:
Transcription
1 StratomeX Visual Analysis of Large-Scale Heterogeneous Genomics Data for Cancer Subtype Characterization Alexander Lex 1, Marc Streit 2, Hans-Jörg Schulz 3, Christian Partl 1, Dieter Schmalstieg 1, Peter J. Park 4, Nils Gehlenborg 4,5 1 Graz University of Technology, Austria 2 Johannes Kepler University Linz, Austria 3 University of Rostock, Germany 4 Center for Biomedical Informatics, Harvard Medical School, Boston, MA, USA 5 Cancer Program, Broad Institute, Cambridge, MA, USA 1
2 Cancer Subtypes Cancer Subtypes have different histology different molecular alterations Subtypes have serious implications different treatment for subtypes prognosis varies between subtypes 2
3 Cancer Subtype Analysis Modern cancer subtype analysis based on biomolecular data Our Goal: Support cancer subtype characterization through integrative visual analysis of multiple relevant datasets. 3
4 4
5 How Subtypes are Visualized Patients 5
6 Challenges Challenge 1: Visualize complex interdependencies between multiple datasets 6
7 StratomeX: Interdependencies between Stratifications of Datasets 7
8 Challenges Challenge 1: Visualize complex interdependencies between multiple datasets Challenge 2: Manage complex setup of multiple datasets, multiple stratifications and multiple views 8
9 Data View Integrator 9
10 THE DATA 10
11 TCGA Large-scale project to catalogue genetic mutations responsible for cancer 20 tumor types 500 patient samples each Extensive molecular profiling for each patient 11
12 expression TCGA Data Gene Protein sequencing data microrna expression clinical parameters mrna expression pathways methylation levels copy number status mutation status 12
13 THE TECHNIQUE 13
14 Patients Tabular Stratification Data Subtypes are identified by stratifying datasets, e.g., based on an expression pattern a mutation status a copy number alteration a combination of these Brick Various Stuff Column 14
15 Tasks T1 Evaluate whether stratifications support each other T2 Refine stratifications T3 Review effect of stratifications on clinical outcomes on pathways T4 Show expression patterns in subtypes Elicited in expert interviews and literature review 15
16 Stratification of a Single Dataset 16
17 Stratification of Multiple Datasets Cluster A1 B1 Cluster A2 B2 T1 Evaluate whether stratifications support each other Cluster A3 Tabular Data Categorical Data 17
18 VisBricks Parallel Sets [Lex, InfoVis 2011] [Kosara, InfoVis 2006] 18
19 Stratification of Multiple Datasets Cluster A1 B1 Cluster A2 B2 Cluster A3 Tabular Data Categorical Data 19
20 Stratification of Multiple Datasets Cluster A1 B1 B2.1 Cluster A2 B2.2 T2 Refine stratifications Cluster A3 Tabular Data Categorical Data 20
21 Stratification of Multiple Datasets Cluster A1 B1 Dep. C1 B2.1 Cluster A2 Dep. C2.1 B2.2 T3 Review effect of stratification Dep. C2.2 Cluster A3 Tabular Data Categorical Data Dependent Data, e.g. clinical, pathways 21
22 Column Classes T4 Show expression patterns in subtypes Table Categorical Dependent 22
23 Live Demo Glioblastoma Multiforme 23
24 Conducted with two domain experts from Broad Institute of MIT and Harvard Datasets Glioblastoma Multiforme Breast Invasive Carcinoma Report on findings Methylation subtypes Effects of clustering Effects on Pathways Case Studies 24
25 Implementation Part of Caleydo Caleydo is now open source! Release weeks ago Includes Glioblastoma dataset 25
26 ? Marc Streit Hans-Jörg Schulz Christian Partl Dieter Schmalstieg Peter J. Park Nils Gehlenborg StratomeX Visual Analysis of Large-Scale Heterogeneous Genomics Data for Cancer Subtype Characterization 26
27 Case Studies Glioblastoma Multiforme 27
28 Effects on Pathways 28
29 Effects on Pathways 29
30 Methylation Subtypes 30
31 Clustering Effects 31
Characterizing Cancer Subtypes Using Dual Analysis in Caleydo StratomeX
Visual Analytics for Biological Data Characterizing Cancer Subtypes Using Dual Analysis in Caleydo StratomeX Cagatay Turkay City University London Alexander Lex Harvard University Marc Streit Johannes
More informationSupplementary Information
Supplementary Information Guided Visual Exploration of Genomic Stratifications in Cancer Marc Streit 1,6, Alexander Lex 2,6, Samuel Gratzl¹, Christian Partl³, Dieter Schmalstieg³, Hanspeter Pfister², Peter
More informationStratomeX: Visual Analysis of Large-Scale Heterogeneous Genomics Data for Cancer Subtype Characterization
Eurographics Conference on Visualization (EuroVis) 2012 S. Bruckner, S. Miksch, and H. Pfister (Guest Editors) Volume 31 (2012), Number 3 StratomeX: Visual Analysis of Large-Scale Heterogeneous Genomics
More informationcorrespondence Guided visual exploration of genomic stratifications in cancer npg 2014 Nature America, Inc. All rights reserved.
correspondence npg 2014 Nature America, Inc. All rights reserved. motor behaviors. The first was the forward optomotor response (OMR) 1,2, in which swimming is elicited by visual gratings moving in the
More informationExploring TCGA Pan-Cancer Data at the UCSC Cancer Genomics Browser
Exploring TCGA Pan-Cancer Data at the UCSC Cancer Genomics Browser Melissa S. Cline 1*, Brian Craft 1, Teresa Swatloski 1, Mary Goldman 1, Singer Ma 1, David Haussler 1, Jingchun Zhu 1 1 Center for Biomolecular
More informationVisualizing Uncertainty in Biological Expression Data
Visualizing Uncertainty in Biological Expression Data Clemens Holzhüter a, Alexander Lex b, Dieter Schmalstieg b, Hans-Jörg Schulz b, Heidrun Schumann a and Marc Streit c a University of Rostock, Department
More informationIntroduction to Gene Sets Analysis
Introduction to Svitlana Tyekucheva Dana-Farber Cancer Institute May 15, 2012 Introduction Various measurements: gene expression, copy number variation, methylation status, mutation profile, etc. Main
More informationInference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics, 2010
Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics, 2010 C.J.Vaske et al. May 22, 2013 Presented by: Rami Eitan Complex Genomic
More informationASMS 2015 ThP 459 Glioblastoma Multiforme Subtype Classification: Integrated Analysis of Protein and Gene Expression Data
ASMS 2015 ThP 459 Glioblastoma Multiforme Subtype Classification: Integrated Analysis of Protein and Gene Expression Data Durairaj Renu 1, Vadiraja Bhat 2, Mona Al-Gizawiy 3, Carolina B. Livi 2, Stephen
More informationContemporary Classification of Breast Cancer
Contemporary Classification of Breast Cancer Laura C. Collins, M.D. Vice Chair of Anatomic Pathology Professor of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA Outline
More informationSession 4 Rebecca Poulos
The Cancer Genome Atlas (TCGA) & International Cancer Genome Consortium (ICGC) Session 4 Rebecca Poulos Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 20
More informationThe Cancer Genome Atlas
The Cancer Genome Atlas July 14, 2011 Kenna M. Shaw, Ph.D. Deputy Director The Cancer Genome Atlas Program TCGA: Core Objectives Launched in 2006 as a pilot and expanded in 2009, the goals of TCGA are
More informationSession 4 Rebecca Poulos
The Cancer Genome Atlas (TCGA) & International Cancer Genome Consortium (ICGC) Session 4 Rebecca Poulos Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 28
More informationNature Methods: doi: /nmeth.3115
Supplementary Figure 1 Analysis of DNA methylation in a cancer cohort based on Infinium 450K data. RnBeads was used to rediscover a clinically distinct subgroup of glioblastoma patients characterized by
More informationAdvances in Brain Tumor Research: Leveraging BIG data for BIG discoveries
Advances in Brain Tumor Research: Leveraging BIG data for BIG discoveries Jill Barnholtz-Sloan, PhD Associate Professor & Associate Director for Bioinformatics and Translational Informatics jsb42@case.edu
More informationComputer Science, Biology, and Biomedical Informatics (CoSBBI) Outline. Molecular Biology of Cancer AND. Goals/Expectations. David Boone 7/1/2015
Goals/Expectations Computer Science, Biology, and Biomedical (CoSBBI) We want to excite you about the world of computer science, biology, and biomedical informatics. Experience what it is like to be a
More informationBiomarker development in the era of precision medicine. Bei Li, Interdisciplinary Technical Journal Club
Biomarker development in the era of precision medicine Bei Li, 23.08.2016 Interdisciplinary Technical Journal Club The top ten highest-grossing drugs in the United States help between 1 in 25 and 1 in
More informationMEETING SUMMARY ECC 2015, SEPTEMBER 25TH 29TH 2015 BY PROF. DR. HANS PRENEN, LEUVEN, BELGIUM. Cancers of the Upper GI Tract
Supported by an Independent Educa1onal Grant from MEETING SUMMARY ECC 2015, SEPTEMBER 25TH 29TH 2015 BY PROF. DR. HANS PRENEN, LEUVEN, BELGIUM Cancers of the Upper GI Tract RE-CLASSIFICATION OF GO CANCER
More informationCancer troublemakers: a tale of usual suspects and novel villains
Cancer troublemakers: a tale of usual suspects and novel villains Abel González-Pérez and Núria López-Bigas Biomedical Genomics Group Lab web: http://bg.upf.edu Driver genes/mutations: the troublemakers
More informationA Versatile Algorithm for Finding Patterns in Large Cancer Cell Line Data Sets
A Versatile Algorithm for Finding Patterns in Large Cancer Cell Line Data Sets James Jusuf, Phillips Academy Andover May 21, 2017 MIT PRIMES The Broad Institute of MIT and Harvard Introduction A quest
More information10/15/2012. Biologic Subtypes of TNBC. Topics. Topics. Histopathology Molecular pathology Clinical relevance
Biologic Subtypes of TNBC Andrea L. Richardson M.D. Ph.D. Brigham and Women s Hospital Dana-Farber Cancer Institute Harvard Medical School Boston, MA Topics Histopathology Molecular pathology Clinical
More informationClasificación Molecular del Cáncer de Próstata. JM Piulats
Clasificación Molecular del Cáncer de Próstata JM Piulats Introduction The Gleason score is the major method for prostate cancer tissue grading and the most important prognostic factor in this disease.
More informationmicrorna Presented for: Presented by: Date:
microrna Presented for: Presented by: Date: 2 micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved Regulate gene expression by binding complementary regions at 3 regions
More informationAccepted Manuscript. Pancreatic Cancer Subtypes: Beyond Lumping and Splitting. Andrew J. Aguirre
Accepted Manuscript Pancreatic Cancer Subtypes: Beyond Lumping and Splitting Andrew J. Aguirre PII: S0016-5085(18)35213-2 DOI: https://doi.org/10.1053/j.gastro.2018.11.004 Reference: YGAST 62235 To appear
More informationSession 6: Integration of epigenetic data. Peter J Park Department of Biomedical Informatics Harvard Medical School July 18-19, 2016
Session 6: Integration of epigenetic data Peter J Park Department of Biomedical Informatics Harvard Medical School July 18-19, 2016 Utilizing complimentary datasets Frequent mutations in chromatin regulators
More informationPackage diggitdata. April 11, 2019
Type Package Title Example data for the diggit package Version 1.14.0 Date 2014-08-29 Author Mariano Javier Alvarez Package diggitdata April 11, 2019 Maintainer Mariano Javier Alvarez
More informationAgilent GeneSpring/MPP Metadata Analysis Framework
Agilent GeneSpring/MPP Metadata Analysis Framework Technical Overview Authors Srikanthi R., Pritha Aggarwal, Durairaj R., Maria Kammerer, and Pramila Tata Strand Life Sciences Bangalore, India Michael
More informationImportance of Methodology Certification and Accreditations to Perform Assays. Stan Hamilton, MD Head, Pathology and Laboratory Medicine
Importance of Methodology Certification and Accreditations to Perform Assays Stan Hamilton, MD Head, Pathology and Laboratory Medicine 1 Disclosures No disclosures relevant to this presentation 2 A bad
More informationVisualizing Molecular Profiles of Glioblastoma with GBM-BioDP
Visualizing Molecular Profiles of Glioblastoma with GBM-BioDP Orieta Celiku, Seth Johnson, Shuping Zhao, Kevin Camphausen, Uma Shankavaram* Radiation Oncology Branch, National Cancer Institute, National
More informationThe Cancer Genome Atlas Pan-cancer analysis Katherine A. Hoadley
The Cancer Genome Atlas Pan-cancer analysis Katherine A. Hoadley Department of Genetics Lineberger Comprehensive Cancer Center The University of North Carolina at Chapel Hill What is TCGA? The Cancer Genome
More informationIdentifying Thyroid Carcinoma Subtypes and Outcomes through Gene Expression Data Kun-Hsing Yu, Wei Wang, Chung-Yu Wang
Identifying Thyroid Carcinoma Subtypes and Outcomes through Gene Expression Data Kun-Hsing Yu, Wei Wang, Chung-Yu Wang Abstract: Unlike most cancers, thyroid cancer has an everincreasing incidence rate
More informationNew Opportunities in Cancer Research National Academy of Sciences Advancing Health Research in Poland and the United States December 3, 2009
New Opportunities in Cancer Research National Academy of Sciences Advancing Health Research in Poland and the United States December 3, 2009 Anna D. Barker, Ph.D. Deputy Director, NCI Cancer is a Current
More informationDeveloping New Therapies to Treat Glioblastoma
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/focus-on-cancer/developing-new-therapies-to-treat-glioblastoma/4077/
More informationSignificance Analysis of Prognostic Signatures
Andrew H. Beck 1 *, Nicholas W. Knoblauch 1, Marco M. Hefti 1, Jennifer Kaplan 1, Stuart J. Schnitt 1, Aedin C. Culhane 2,3, Markus S. Schroeder 2,3, Thomas Risch 2,3, John Quackenbush 2,3,4, Benjamin
More informationMicroRNA expression profiling and functional analysis in prostate cancer. Marco Folini s.c. Ricerca Traslazionale DOSL
MicroRNA expression profiling and functional analysis in prostate cancer Marco Folini s.c. Ricerca Traslazionale DOSL What are micrornas? For almost three decades, the alteration of protein-coding genes
More informationIdentifying Novel Targets for Non-Small Cell Lung Cancer Just How Novel Are They?
Identifying Novel Targets for Non-Small Cell Lung Cancer Just How Novel Are They? Dubovenko Alexey Discovery Product Manager Sonia Novikova Solution Scientist September 2018 2 Non-Small Cell Lung Cancer
More informationMetabolomic and Proteomics Solutions for Integrated Biology. Christine Miller Omics Market Manager ASMS 2015
Metabolomic and Proteomics Solutions for Integrated Biology Christine Miller Omics Market Manager ASMS 2015 Integrating Biological Analysis Using Pathways Protein A R HO R Protein B Protein X Identifies
More informationMethylMix An R package for identifying DNA methylation driven genes
MethylMix An R package for identifying DNA methylation driven genes Olivier Gevaert May 3, 2016 Stanford Center for Biomedical Informatics Department of Medicine 1265 Welch Road Stanford CA, 94305-5479
More informationASU-Mayo Clinic Imaging Informatics Laboratory (AMIIL)
ASU-Mayo Clinic Imaging Informatics Laboratory (AMIIL) 1 ASU-Mayo Clinic Imaging Informatics Laboratory (AMIIL) http://amiil.engineering.asu.edu/ Focus Area I: Imaging-centered data analytics for better
More informationThe Cancer Genome Atlas & International Cancer Genome Consortium
The Cancer Genome Atlas & International Cancer Genome Consortium Session 3 Dr Jason Wong Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 31 st July 2014 1
More informationCase presentation 04/13/2017. Genomic/morphological classification of endometrial carcinoma
Genomic/morphological classification of endometrial carcinoma Robert A. Soslow, MD soslowr@mskcc.org architecture.about.com Case presentation 49 year old woman with vaginal bleeding Underwent endometrial
More informationSupplemental Information. Integrated Genomic Analysis of the Ubiquitin. Pathway across Cancer Types
Cell Reports, Volume 23 Supplemental Information Integrated Genomic Analysis of the Ubiquitin Pathway across Zhongqi Ge, Jake S. Leighton, Yumeng Wang, Xinxin Peng, Zhongyuan Chen, Hu Chen, Yutong Sun,
More informationResults and Discussion of Receptor Tyrosine Kinase. Activation
Results and Discussion of Receptor Tyrosine Kinase Activation To demonstrate the contribution which RCytoscape s molecular maps can make to biological understanding via exploratory data analysis, we here
More informationPatient networks! in cancer:! a platform for data integration
Anna Goldenberg and The Goldenberg Lab Patient networks! in cancer:! a platform for data integration Outline o Data integra-on problem setup o Pa-ent network representa-on why and how o Similarity Network
More informationSemester Report. Winter Semester 2013/14. Doctoral College. Molecular Fundamentals of Inflammation (DK-MOLIN)
Semester Report Winter Semester 2013/14 Doctoral College Molecular Fundamentals of Inflammation (DK-MOLIN) Medical University of Graz 1 October 2013 04.10. Guest Lecture Metabolomics in infectious and
More informationBasket and Umbrella Trial Designs in Oncology
Basket and Umbrella Trial Designs in Oncology Eric Polley Biomedical Statistics and Informatics Mayo Clinic Polley.Eric@mayo.edu Dose Selection for Cancer Treatment Drugs Stanford Medicine May 2017 1 /
More informationQuestion 1 A. ER-, PR-, HER+ B. ER+, PR+, HER2- C. ER-, PR+, HER2- D. ER-, PR-, HER2- E. ER-, PR+, HER2+
Triple Negative Breast Cancer Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA Question 1 The tumor depicted on the next slide
More informationImproving quality of care for patients with ovarian and endometrial cancer Eggink, Florine
University of Groningen Improving quality of care for patients with ovarian and endometrial cancer Eggink, Florine IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if
More informationUnderstanding Genotype- Phenotype relations in Cancer via Network Approaches
AlgoCSB Algorithmic Methods in Computational and Systems Biology Understanding Genotype- Phenotype relations in Cancer via Network Approaches Teresa Przytycka NIH / NLM / NCBI Phenotypes Journal Wisla
More informationGenetic alterations of histone lysine methyltransferases and their significance in breast cancer
Genetic alterations of histone lysine methyltransferases and their significance in breast cancer Supplementary Materials and Methods Phylogenetic tree of the HMT superfamily The phylogeny outlined in the
More information"BRCAness," PARP and the Triple-Negative Phenotype
"BRCAness," PARP and the Triple-Negative Phenotype Prof Alan Ashworth, FRS Disclosures for Professor Alan Ashworth, FRS Consulting Agreements GlaxoSmithKline, Pfizer Inc Patent AstraZeneca Pharmaceuticals
More informationfor the TCGA Breast Phenotype Research Group
Decoding Breast Cancer with Quantitative Radiomics & Radiogenomics: Imaging Phenotypes in Breast Cancer Risk Assessment, Diagnosis, Prognosis, and Response to Therapy Maryellen Giger & Yuan Ji The University
More informationQuantitative Radiomics System Decoding the Tumor Phenotype. John Quackenbush and Hugo Aerts
Quantitative Radiomics System Decoding the Tumor Phenotype John Quackenbush and Hugo Aerts The Radiomics Hypothesis The tumor s structural phenotype reflects its molecular and clinical properties. This
More informationPredicting Non-Small Cell Lung Cancer Diagnosis and Prognosis by Fully Automated Microscopic Pathology Image Features
Predicting Non-Small Cell Lung Cancer Diagnosis and Prognosis by Fully Automated Microscopic Pathology Image Features Kun-Hsing Yu, MD, PhD Department of Biomedical Informatics, Harvard Medical School
More informationCancer Informatics Lecture
Cancer Informatics Lecture Mayo-UIUC Computational Genomics Course June 22, 2018 Krishna Rani Kalari Ph.D. Associate Professor 2017 MFMER 3702274-1 Outline The Cancer Genome Atlas (TCGA) Genomic Data Commons
More informationSUPPLEMENTARY FIGURES: Supplementary Figure 1
SUPPLEMENTARY FIGURES: Supplementary Figure 1 Supplementary Figure 1. Glioblastoma 5hmC quantified by paired BS and oxbs treated DNA hybridized to Infinium DNA methylation arrays. Workflow depicts analytic
More informationPredictive Biomarkers in GBM
Predictive Biomarkers in GBM C. David James, Ph.D. Professor & Associate Director, Brain Tumor Research Center Dept. Neurological Surgery and Helen Diller Comprehensive Cancer Center, University of California
More informationCancerLinker: Explorations of Cancer Study Network
CancerLinker: Explorations of Cancer Study Network Vinh Nguyen, Md Yasin Kabir, and Tommy Dang Figure 1. Overview of CancerLinker; a) Control panel of CancerLinker, b) The merged network of twenty-six
More informationBayesian Prediction Tree Models
Bayesian Prediction Tree Models Statistical Prediction Tree Modelling for Clinico-Genomics Clinical gene expression data - expression signatures, profiling Tree models for predictive sub-typing Combining
More informationUniversity of Pittsburgh Cancer Institute UPMC CancerCenter. Uma Chandran, MSIS, PhD /21/13
University of Pittsburgh Cancer Institute UPMC CancerCenter Uma Chandran, MSIS, PhD chandran@pitt.edu 412-648-9326 2/21/13 University of Pittsburgh Cancer Institute Founded in 1985 Director Nancy Davidson,
More informationConference Program. Genomic heterogeneity in localized lung cancer Andrew Futreal, The University of Texas MD Anderson Cancer Center, Houston, TX
NOTE: Saturday, February 7 1:00 p.m.-3:00 p.m. Session A1: Cancer Genomics and Epigenomics Session Chairperson: Levi A. Garraway, Dana-Farber Cancer Institute, Boston, MA Genomic heterogeneity in localized
More informationModule 3: Pathway and Drug Development
Module 3: Pathway and Drug Development Table of Contents 1.1 Getting Started... 6 1.2 Identifying a Dasatinib sensitive cancer signature... 7 1.2.1 Identifying and validating a Dasatinib Signature... 7
More informationComposer: Visual Cohort Analysis of Patient Outcomes. Jennifer Rogers, Nicholas Spina, Ashley Neese, Rachel Hess, Darrel Brodke, Alexander Lex
Composer: Visual Cohort Analysis of Patient Outcomes Jennifer Rogers, Nicholas Spina, Ashley Neese, Rachel Hess, Darrel Brodke, Alexander Lex 1 Lower Back Pain is a Significant Health Burden 2.6 Million
More informationncounter Assay Automated Process Immobilize and align reporter for image collecting and barcode counting ncounter Prep Station
ncounter Assay ncounter Prep Station Automated Process Hybridize Reporter to RNA Remove excess reporters Bind reporter to surface Immobilize and align reporter Image surface Count codes Immobilize and
More informationBreast cancer classification: beyond the intrinsic molecular subtypes
Breast cancer classification: beyond the intrinsic molecular subtypes Britta Weigelt, PhD Signal Transduction Laboratory CRUK London Research Institute Summary Breast cancer heterogeneity Molecular classification
More informationPredicting clinical outcomes in neuroblastoma with genomic data integration
Predicting clinical outcomes in neuroblastoma with genomic data integration Ilyes Baali, 1 Alp Emre Acar 1, Tunde Aderinwale 2, Saber HafezQorani 3, Hilal Kazan 4 1 Department of Electric-Electronics Engineering,
More informationOriginal Article International Cancer Genome Consortium Data Portal a one-stop shop for cancer genomics data
Original Article International Cancer Genome Consortium Data Portal a one-stop shop for cancer genomics data Junjun Zhang 1, Joachim Baran 1, A. Cros 1, Jonathan M. Guberman 1, Syed Haider 2, Jack Hsu
More informationIntroduction to Systems Biology of Cancer Lecture 2
Introduction to Systems Biology of Cancer Lecture 2 Gustavo Stolovitzky IBM Research Icahn School of Medicine at Mt Sinai DREAM Challenges High throughput measurements: The age of omics Systems Biology
More informationExpanded View Figures
Solip Park & Ben Lehner Epistasis is cancer type specific Molecular Systems Biology Expanded View Figures A B G C D E F H Figure EV1. Epistatic interactions detected in a pan-cancer analysis and saturation
More informationCase Studies on High Throughput Gene Expression Data Kun Huang, PhD Raghu Machiraju, PhD
Case Studies on High Throughput Gene Expression Data Kun Huang, PhD Raghu Machiraju, PhD Department of Biomedical Informatics Department of Computer Science and Engineering The Ohio State University Review
More informationHealth Inequity and Controversies in Cancer Screening. Doris Browne, MD, MPH Immediate Past President, NMA September
Health Inequity and Controversies in Cancer Screening Doris Browne, MD, MPH Immediate Past President, NMA September 12 2018 DISCLOSURE In compliance with ACCME Guidelines, I hereby declare: I do not have
More informationZNZ Annual Symposium 2017
ZNZ Annual Symposium 2017 Thursday, 14 September 2017 UZH Central Campus, Lecture Hall HAH E3, Häldeliweg 2, Zurich 8:30 8:45 Introduction Prof. Fritjof Helmchen, Director ZNZ 8:45 9:30 Volker-Henn Lecture
More informationNature Medicine: doi: /nm.3967
Supplementary Figure 1. Network clustering. (a) Clustering performance as a function of inflation factor. The grey curve shows the median weighted Silhouette widths for varying inflation factors (f [1.6,
More informationAtypical Ductal Hyperplasia and Papillomas: A Comparison of Ultrasound Guided Breast Biopsy and Stereotactic Guided Breast Biopsy
Atypical Ductal Hyperplasia and Papillomas: A Comparison of Ultrasound Guided Breast Biopsy and Stereotactic Guided Breast Biopsy Breast Cancer is the most common cancer diagnosed in women in the United
More informationPredicting outcome from cancer data
Predicting outcome from cancer data Jeffrey Chuang The Jackson Laboratory for Genomic Medicine Drowning in data, thirsting for knowledge 2 Clinical outcome across cancer types TCGA Cancer types 5-year
More informationCharacterisation of structural variation in breast. cancer genomes using paired-end sequencing on. the Illumina Genome Analyser
Characterisation of structural variation in breast cancer genomes using paired-end sequencing on the Illumina Genome Analyser Phil Stephens Cancer Genome Project Why is it important to study cancer? Why
More informationIPATIMUP Translational Research Unit Matching IPATIMUP s Expertise with Company s Research/Clinical Strategy
IPATIMUP Translational Research Unit Matching IPATIMUP s Expertise with Company s Research/Clinical Strategy Innovative Projects Questions & Needs André Albergaria INDUSTRY Pharma R&D Clinical Research
More informationRefining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 2): Early Steps in Molecularly Defined Prognosis
5/17/13 Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 2): Early Steps in Molecularly Defined Prognosis Johannes Kratz, MD Post-doctoral Fellow, Thoracic Oncology Laboratory
More informationSFMC Breast Cancer Site Study: 2011
SFMC Breast Cancer Site Study: 2011 Introduction Breast cancer is the most frequently diagnosed cancer among American women, except for skin cancers. It is the second leading cause of cancer death in women,
More informationInvasive breast cancer: stratification of histological grade by gene-based assays: a still relevant example from an older data set
Histopathology 14, 65, 429 433. DOI: 1.1111/his.12423 SHORT REPORT Invasive breast cancer: stratification of histological grade by gene-based assays: a still relevant example from an older data set Leslie
More informationDATA STANDARDS AND QUALITY CONTROL MEMORANDUM DSQC #
DATA STANDARDS AND QUALITY CONTROL MEMORANDUM DSQC #2006-01 CATEGORY: CLARIFICATION SUBJECT: RESCINDMENT - DSQC MEMORANDUM 2002-08 Coding Complex Morphologic Diagnoses (revised 8/02) EFFECTIVE: For Cases
More informationNature Immunology: doi: /ni Supplementary Figure 1. RNA-Seq analysis of CD8 + TILs and N-TILs.
Supplementary Figure 1 RNA-Seq analysis of CD8 + TILs and N-TILs. (a) Schematic representation of the tumor and cell types used for the study. HNSCC, head and neck squamous cell cancer; NSCLC, non-small
More informationSUPPLEMENTAL FILE. mir-22 and mir-29a are members of the androgen receptor cistrome modulating. LAMC1 and Mcl-1 in prostate cancer
1 SUPPLEMENTAL FILE 2 3 mir-22 and mir-29a are members of the androgen receptor cistrome modulating LAMC1 and Mcl-1 in prostate cancer 4 5 6 Lorenza Pasqualini 1, Huajie Bu 1,2, Martin Puhr 1, Narisu Narisu
More informationTranscriptional Profiles from Paired Normal Samples Offer Complementary Information on Cancer Patient Survival -- Evidence from TCGA Pan-Cancer Data
Transcriptional Profiles from Paired Normal Samples Offer Complementary Information on Cancer Patient Survival -- Evidence from TCGA Pan-Cancer Data Supplementary Materials Xiu Huang, David Stern, and
More informationTumor Purity and Immune Cell Infiltration as a Prognostic Risk Predictor for Clear Cell Renal Cell Carcinoma (ccrcc)
Tumor Purity and Immune Cell Infiltration as a Prognostic Risk Predictor for Clear Cell Renal Cell Carcinoma (ccrcc) Andrew G. Winer, Yasin Senbabaoglu, Samuel D Kaffenberger, Jonathan A. Coleman, Paul
More informationTriple Negative Breast Cancer
Triple Negative Breast Cancer Prof. Dr. Pornchai O-charoenrat Division of Head-Neck & Breast Surgery Department of Surgery Faculty of Medicine Siriraj Hospital Breast Cancer Classification Traditional
More informationHER2 FISH pharmdx TM Interpretation Guide - Breast Cancer
P A T H O L O G Y HER2 FISH pharmdx TM Interpretation Guide - Breast Cancer For In Vitro Diagnostic Use FDA approved as an aid in the assessment of patients for whom Herceptin TM (trastuzumab) treatment
More informationThe Cancer Genome Atlas Project Overview
TheCancerGenomeAtlasProjectOverview InSeptember2006,TheCancerGenomeAtlas(TCGA)programannouncedplanstomap genomicchangesoflung,brainandovariancancertumorsusinglargescalesequencing technologies. Seven institutions
More informationMapping by recurrence and modelling the mutation rate
Mapping by recurrence and modelling the mutation rate Shamil Sunyaev Broad Institute of M.I.T. and Harvard Current knowledge is from Comparative genomics Experimental systems: yeast reporter assays Potential
More informationSupplementary Figures
Supplementary Figures Supplementary Figure 1. Pan-cancer analysis of global and local DNA methylation variation a) Variations in global DNA methylation are shown as measured by averaging the genome-wide
More informationExpert-guided Visual Exploration (EVE) for patient stratification. Hamid Bolouri, Lue-Ping Zhao, Eric C. Holland
Expert-guided Visual Exploration (EVE) for patient stratification Hamid Bolouri, Lue-Ping Zhao, Eric C. Holland Oncoscape.sttrcancer.org Paul Lisa Ken Jenny Desert Eric The challenge Given - patient clinical
More informationmirna Dr. S Hosseini-Asl
mirna Dr. S Hosseini-Asl 1 2 MicroRNAs (mirnas) are small noncoding RNAs which enhance the cleavage or translational repression of specific mrna with recognition site(s) in the 3 - untranslated region
More informationBiology of Ovarian Cancer
Biology of Ovarian Cancer John W. Moroney, M.D. Associate Professor Department of Obstetrics and Gynecology Department of Medicine University of Chicago Pritzker School of Medicine Disclosure No conflicts
More informationBreast Cancer TAUG Overview and Implementation
Breast Cancer TAUG Overview and Implementation Anita Umesh, Ph.D. Senior Scientist, Enterprise Informatics Illumina, Inc. Bay Area CDISC User Group 9 December 2015 2014 Illumina, Inc. All rights reserved.
More informationJournal: Nature Medicine
Journal: Nature Medicine Article Title: Corresponding Author: TARID1B is a specific vulnerability in ARID1A-mutant cancers Charles W. M. Roberts Supplementary Item & Number Supplementary Figure 1 Supplementary
More informationMolecular Subtyping of Endometrial Cancer: A ProMisE ing Change
Molecular Subtyping of Endometrial Cancer: A ProMisE ing Change Charles Matthew Quick, M.D. Associate Professor of Pathology Director of Gynecologic Pathology University of Arkansas for Medical Sciences
More informationΗ γενετική διερεύνηση είναι απαραίτητη στην κλινική διαχείριση ασθενών με καναλοπάθειες
Η γενετική διερεύνηση είναι απαραίτητη στην κλινική διαχείριση ασθενών με καναλοπάθειες Ε.Χατζηνικολάου-Κοτσάκου Ηλεκτροφυσιολόγος-Επεμβατική Καρδιολόγος ΚΛΙΝΙΚΗ ΑΓΙΟΣ ΛΟΥΚΑΣ-ΘΕΣΣΑΛΟΝΙΚΗ To be honest this
More informationSupplementary Tables. Supplementary Figures
Supplementary Files for Zehir, Benayed et al. Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients Supplementary Tables Supplementary Table 1: Sample
More informationIPA Advanced Training Course
IPA Advanced Training Course October 2013 Academia sinica Gene (Kuan Wen Chen) IPA Certified Analyst Agenda I. Data Upload and How to Run a Core Analysis II. Functional Interpretation in IPA Hands-on Exercises
More informationThe use of diagnostic FFPE material in cancer epidemiology research
The use of diagnostic FFPE material in cancer epidemiology research Neil O Callaghan Genetic Epidemiology Laboratory Department of Pathology The University of Melbourne www.pedigree.org.au Overview Who
More information